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Amniotic fluid derived stem cells
Sheep model
Gene signatureAbnormal cord development results in spinal cord damage responsible for myelomeningocele (MMC). Amniotic
fluid-derived stem cells (AFSCs) have emerged as a potential candidate for applications in regenerativemedicine.
However, their differentiation potential is largely unknown as well as the molecular signaling orchestrating the
accurate spinal cord development. Fetal lambs underwent surgical creation of neural tube defect and its
subsequent repair. AFSCs were isolated, cultured and characterized at the 12th (induction of MMC), 16th (repair
of malformation), and 20th week of gestation (delivery). After performing open hysterectomy, AF collections on
fetuses with sham procedures at the same time points as the MMC creation group have been used as controls.
Cytological analyses with the colony forming unit assay, XTT and alkaline-phosphatase staining, qRT-PCR gene
expression analyses (normalized with aged match controls) and NMR metabolomics profiling were performed.
Here we show for the first time the metabolomics and molecular signature variation in AFSCs isolated in the
sheep model of MMC, which may be used as diagnostic tools for the in utero identification of the neural tube
damage. Intriguingly, PAX3 gene involved in the murine model for spina bifida is modulated in AFSCs reaching
the peak of expression at 16 weeks of gestation, 4 weeks after the intervention. Our data strongly suggest
that AFSCs reorganize their differentiation commitment in order to generate PAX3-expressing progenitors to
counteract theMMC induced in the sheepmodel. The gene expression signature of AFSCs highlights the plasticity
of these cells reflecting possible alterations of embryonic development.ment of Public Health, Experi-
y, Via Forlanini 8, Pavia, Italy.
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tube defect due to incomplete development of the caudal part of the
neural tube. It presents with protrusion of neural tissue and meninx
through an opening in the vertebral arches [1]. It is associated with
significant morbidity due to lifelong paralysis, bladder incontinence,
bowel dysfunction, hydrocephalus, Arnold Chiari Malformation II and
intellectual disability of different grade [2–4]. It has been hypothesized
that the pathogenesis of the peripheral neurologic defects present at
birth has a double cause, being the abnormal neural tube developmentfirst and the in utero exposure of the open spinal cord to the amniotic
fluid (AF) secondly [5].
In pediatric surgery, classical treatment of MMC consists of surgical
closure of the spinal canal soon after birth. However, lifelong support
as well as rehabilitation and frequent surgeries is necessary [6,7].
Intrauterine repair of MMC improves the neurologic outcome in these
infants since secondary damage and resultant disability are reduced
by closing the defect before childbirth; moreover, halting the loss of
cerebrospinal fluid (CSF) may reverse the neurologic sequelae [8,9].
In recent years, multipotent stem cells have emerged as a strategy
for the clinical approach in the diagnosis and therapy of embryonic de-
fects involving the neural tube [10]. During gestation, themain source of
stem cells is the AF, which contains a heterogeneous population of cells
and stem cells that form the fetal environment. The most promising
cluster of multipotent stem cells is the sub-population of the amnioticcells in the fetal sheepmodel ofmyelomeningocele,
2 G. Ceccarelli et al. / Journal of Pediatric Surgery xxx (2015) xxx–xxxfluid-derived stem cells (AFSCs). The AFSCs have the ability to differen-
tiate in various lineages and they can be considered in disease pathology
investigation for the analysis of disease mechanisms. Based on these
findings, we have focused on the isolation and characterization of
AFSCs from MMC model to define possible diagnostic tools to stage
MMC fetuses [11–14].
For this purpose,we have used the sheepmodel ofMMC. By open fetal
surgery, we recreated the original pathology in the fetus at the 12thweek
of gestation [15]. We also planned a second surgery at the 16th week of
gestation to repair the defect by the apposition of a collagen biomatrix
[16]. In both surgical steps and at C-section timewe collected AF samples,
which were subsequently processed to isolate and characterize the cells.
Metabolomic analysis was performed on AF samples collected after
MMC repair (20th week AF) to assess the metabolites variance after
the intervention. In addition, we performed qRT-PCR on AFSCs isolated
from samples collected at the different stages of the study to identify a
cluster of genes that change their expression in the presence of neural
tube defects.
Taken together, these results have revealed for the first time the
gene signature of sheep AFSCs in MMC model, which have unveiled a
different expression pattern of a mesodermal gene cluster. Hence, this
genemodulationmay represent a potential tool for the detection of bio-
markers useful in the prenatal evaluation and management of MMC.
1. Materials and methods
The experimental protocolwas approvedbyNational Animal Care and
Ethics Committee and was conducted in accordance with Italian and
European legislation (D.lgs. 116/92, European Directives 86/609/EE for
the protection of animals used in scientific and experimental studies
and 2010-63UE).
Amniotic fluids (AFs) were collected from MMC fetal lamb. AFSCs
were isolated, cultured and characterized at MMC induction (12th week
gestation), at repair of themalformation (16thweek gestation) and at de-
livery (20th week gestation). AF collections on fetuses with sham proce-
dures at the same time points as the MMC creation group have beenFig. 1. Schematic representationof the study. Surgery and isolation of amnioticfluid-derived s
20th week). AF collections on fetuses with sham procedures at the same time points as the MM
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(CFU) assay, cell proliferation kit (XTT), alkaline-phosphatase (AP) stain-
ing, gene expression analyses with quantitive real-time PCR (qRT-PCR)
and nuclear magnetic resonance (NMR)-based metabolomic profiling
were performed (as summarized in Fig. 1).
1.1. Surgery
At the 12th week of gestation, fetal lambs underwent surgery to in-
duce a neuro-tubal defect. The procedure of laparotomy and hysterotomy
in the pregnant sheepwith the subsequent laminectomy of the fetal lamb
has been performed using the surgical technique previously described by
Meuli et al. [15] Using the same surgical technique, the sheep underwent
a second surgery at the 16thweek of gestation to repair the neural defect.
The MMC defect was covered with a collagen biomatrix for dura repair
(TissuDura®). Caesarean-sectionwas performed at the 20thweek of ges-
tation. AF was collected, and the fetus immediately sacrificed with an in-
jection of barbiturate through the umbilical cord.
1.2. Isolation of AFSCs
Wecollected theAF at the timeof the opening of the uterus frompreg-
nant sheep at 12 weeks, 16 weeks and 20 weeks of gestation using a 22-
gauge, 15-cmecho-tip needle (CookMedical, USA). A volumeof 10–20ml
of AF was collected from each amniotic sac. Cells were resuspended and
subsequently cultured using a recently published protocol [13]. After
approximately 7 days, non-adherent cells and debris were discharged
while adherent cells were cultured until pre-confluence. Subsequently,
adherent cells were detached by using 1%Trypsin (Sigma-Aldrich®,
Saint-Louis, MO, USA) and passed in T75 flasks for their expansion.
1.3. Alkaline phosphatase (AP) staining and colony forming unit (CFU) assay
In order to detect AP activity normally present in all stem cells [17],
the BM Purple AP substrate precipitating (Roche®)was used and added
to cell culture medium following the manufacturer’s instructions.tem cells (AFSCs)were performed at different phases of pregnancy (12thweek, 16thweek,
C creation group have been used as controls.
fluid derived stemcells in the fetal sheepmodel ofmyelomeningocele,
3G. Ceccarelli et al. / Journal of Pediatric Surgery xxx (2015) xxx–xxxFor CFU assay, AFSCs were diluted and seeded in a 96-well culture
plate to obtain approximately 1 cell per well. The cells were observed
daily for 1 to 2weeks to examine colony formation, without anymedium
changing. At the end of the culture period, the cells were stained with
Wright’s staining and CFUs were quantified by counting the colonies.1.4. Characterization of AFSCs by real-time PCR (qRT-PCR)
In order to characterize the isolated and cultured AFSCs, total RNA of
each sample (12th, 16th and 20th week of gestation) was extracted
using PureLink RNA Mini Kit (Ambion). The DNase I treatment was per-
formed using the DNA-free kit (Ambion), and the subsequent reverse
transcriptionwas performed using the Superscript III First-Strand Synthe-
sis SuperMix (Invitrogen). A 384-well plate was prepared using Platinum
SYBRGreenqPCRSuperMix-UDG (Invitrogen) as SYBRGreen. A volume of
10 μL for each well was used. Gene expression was analyzed in triplicate
and normalized to the CTmean of glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) and beta actin (ACTB) gene expression. To perform the
characterization by RT-PCR, we used Invitrogen™ (Carlsbad, California)
primers for the genes and listed in Table 1.1.5. Cell proliferation kit (XTT)
The cell proliferation kit (XTT) assaywas used as a standardmethod to
evaluate cell proliferation [18] bymeans of the assessment of cellularme-
tabolism with spectrophotometry. AFSCs were plated at 5000 cells/cm2
on a 24-well plate, with an area of 1.76 cm2/well. The XTT reagent
(Roche™ kit, Basel, Switzerland) was added to each well. The reagent
was left to react for four hours and afterwards an ELISA™ system was
used to read light absorbance at 562 nm. Light absorbance is proportional
to metabolic activity of the cells. A standard curve was used to quantify
the samples.1.6. Metabolomics analysis
1D 1H NMR spectra were acquired and processed according to meta-
bolomics standard protocols reported in literature [19] using a
BrukerAvance spectrometer operating at 500 MHz (BrukerBioSpin) with
a working temperature of 298 K.
NMR data were transformed into a numeric matrix by means of the
division into segments of 0.04 +/− 0.02 ppmwith subsequent area in-
tegration. The bucket table was normalized and scaled by standard de-
viation relative to the metabolite. These procedures aim to make
comparable different spectra and make all metabolites equally impor-
tant regardless of their absolute intensity [20].Table 1
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Each experiment was performed in triplicate. Results are expressed
as the mean ± standard deviation. In order to compare the results ob-
tained from AF samples one-way analysis of variance (ANOVA) with
post hoc Bonferroni test was applied with a significance level of 0.05.
2. Results
2.1. Characterization of AFSCs
The schematic representation of this study is reported in Fig. 1. We
analyzed the proliferative and clonogenic activity of the AFSCs at
12weeks, 16weeks and 20weeks of gestation (Fig. 2). From amorpho-
logical point of view, the cells have a mesenchymal appearance with a
spindlemorphology (Fig. 2C, left panel) and show a significant AP stain-
ing (Fig. 2C, right panel and inset). Intriguingly, CFU shows an increased
clonogenic activity of the AFSCs at 16 weeks with respect to 12 and
20weeks (p b 0.0001; Fig. 2A). Similarly, the AFSCs exhibit an increased
proliferative activity 4 weeks after the creation of the MMC damage
(p b 0.05; Fig. 2B). Taken together these characteristics demonstrate
an enhanced stemness of AFSCs after the MMC induction.
2.2. Assessment of molecular mesenchymal characteristics of AFSCs
In order to demonstrate the mesenchymal characteristics of AFSCs at
themolecular level, we performed qRT-PCR to evaluate the gene expres-
sion of the key mesenchymal markers at 12, 16 and 20 weeks of gesta-
tion. To standardize the gene expression results, the CT mean of
housekeeping genes GAPDH and ACTB was used. Cells show simulta-
neous expression of cell surface mesenchymal markers CD29, CD90,
CD105 andCD44with a concomitant absence of the hematopoieticmark-
er CD45 (p b 0.05; Fig. 3). Interestingly, CD34 is absent at 12weekswhile
itsmolecular expression is significantly increased at 16 and 20weeks, co-
incident with the MMC damage. This expression pattern represents a
specific phenotype for cultured MSC [13]. Therefore, sheep AFSCs result
as mesenchymal stem cells in all three stages of the experiment.
2.3. Gene signature profiling
In order to define the transcriptional gene pattern of AFSCs at different
phases of the study, we performed qRT-PCR on several genes (Fig. 4A).
The cluster of analyzed genes included GFAP (glial fibrillary acidic
protein, marker of astrocytes cells), PCMT1 (protein-L-isoaspartate O-
methyltransferase, involved in protein repair), LASP1 (LIM and SH3
protein 1, involved in actin cytoskeletal organization), MTHFR (methy-
lenetetrahydrofolate reductase, involved in folate cycle) and MTHFD1L
(methylenetetrahydrofolate dehydrogenase-1-like, involved in folate
cycle), PAX3 (paired homeobox 3, involved in myogenesis), HOXD4
(homeobox D4, involved in chondrogenesis) and HOXC8 (homeobox
C8, involved in osteogenesis). Four weeks after the induction of MMC
damage, PAX3, HOXD4 and HOXC8 have a dramatic increase in expres-
sion compared to the other samples (*p b 0.05 and §p b 0.0001; Fig. 4B).
These results suggest a change in the molecular behavior of AFSCs cor-
responding with the induction of neural tube defect.
2.4. Metabolic changes after MMC damage
The NMR analysis provided an overview of the main differences
concerning hydrosoluble metabolites. The spectra are dominated by
broad intense signals, falling in the range between 3.5 and 4.2 ppm
representing likely oligosaccharides [21].
Other intense features are due to lactic acid, creatine, creatinine, and
myo-inositol. The resulting NMR spectra of MMC and control AF show
an overall similar profile. However, some remarkable differences are
present and emphasized by plotting the normalized-scaled values versusfluid derived stem cells in the fetal sheepmodel ofmyelomeningocele,
Fig. 2. Proliferation analyses andAP+ stainingof AFSCs at different stages of the study.
Colony forming unit (CFU) (A) and XTT analyses (B) of AFSCs at 12, 16 and 20weeks from
the first surgery reveal a peak at 16weeks of active proliferation. Values were normalized
to age-matchedAFSCs from shamoperated animals. AFSCs appear as spindle cells in bright
field (C, left panel) and positive for AP staining (C, right panel and inset). Note that per-
centage of AP positive cells was similar in all samples. Magnification: 10×, scale bar
20 μm. *p b 0.05; §p b 0.0001 with respect to 12 week AFSCs, used as control.
Fig. 3. Characterization of AFSCs by qRT-PCR. AFSCs highly express CD29, CD44, CD90
and CD105 and are negative for CD45. CD34 expression coincides with the MMC damage
and remains even after surgical repair; *p b 0.05; §p b 0.0001with respect to age-matched
AFSCs from sham operated controls. To standardize the gene expression results, the CT
mean of housekeeping genes GAPDH and ACTB was used.
Fig. 4. Gene signature pattern of AFSCs at different stages of the study. (A) AFSCs show
similar expression for folate cycle genes (MTHFR, MTHFD1L), astrocyte marker (GFAP),
protein repair and actin cytoskeletal organization genes (PCMT1 and LASP1 respectively).
(B) In contrast, AFSCs show significant differences in the expression of genes involved in
muscular (PAX3), chondrogenic (HOXD4) and osteogenic (HOXC8) determination at dif-
ferent phases of the experiment; *pb 0.05; §pb 0.0001with respect to age-matchedAFSCs
from sham operated controls; To standardize the gene expression results, the CT mean of
housekeeping genes GAPDH and ACTB was used.
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AF samples collected before the reparative intervention and an increased
Lac/Glc ratio seems to accompany the MMC state after the repair. Finally,
the level of myo-inositol, lactic acid, alanine, isoleucine/leucine, and
valine is considerably higher in AF samples afterMMC repair with respect
to baseline.
3. Discussion
Myelomeningocele is a congenital malformation resulting from
the failed closure of the spine during fetal development. The unprotect-
ed fetal neural tissue undergoes progressive damage with advancing
gestational age [1–4]. In addition, Chiari II malformation of the brain
develops in 95% of fetuses with MMC, presumably due to pressure dis-
turbances resulting from the continuous loss of cerebrospinal fluid
(CSF) [2]. The complex cluster of cerebrospinal problems associated
with MMC may include lower extremity paralysis, urinary and fecal
incontinence and sexual dysfunction due to the spinal cord neural dam-
age, and hydrocephalus, cranial nerve disturbances, respiratory prob-
lems, and death related to Chiari II malformation. The severity of
sensory-motor dysfunction is associated with the level of the vertebral
defect and at term, the child’s neurologic deficits are always irreversible
[3,4]. Experimental studies in animal model have shown that repair of
the neural tube defect in utero results in less severe hindbrain hernia-
tion and spinal cord injury [8,9]. Long-term motor outcome in affected
children also improves. These promising results support in uterofluid derived stemcells in the fetal sheepmodel ofmyelomeningocele,
Fig. 5. Examples of themetabolomics evaluation. (A) NMR spectra of AFs, collected beforeMMC induction (black) and afterMMC repair (red). (B) Bar chart representation of significant
NMR features of AF collected beforeMMC induction (orange bars) and afterMMC repair (green bars). The normalized values were obtained from buckets area as detailed inMaterials and
Methods Section.
5G. Ceccarelli et al. / Journal of Pediatric Surgery xxx (2015) xxx–xxxsurgery. New perspectives in regenerative medical research are needed
to identify autologous tissues for spinal cord coverage as alternatives to
non-biological patches.
Recently emerging literature candidates AFSCs as new source of
stem cells able to differentiate along multiple cell lineages and have
great potential as donor cells for regenerative medicine [11–13], paving
a diagnostic and therapeutic value in prenatal and/or postnatal diseases.
However, their origin, differentiation potential and their relevance as
biomarkers in MMC defects are still largely unknown. Fetal imaging
per se has been shown to be of limited prognostic value [22–24], and
the information obtained from the analysis of bodily fluids (e.g. com-
plete blood count, comparable analyses in urine, cerebrospinal fluid)
has been employed diagnostically for decades to increase the diagnostic
sensibility and give the opportunity of an earlier andmore accurate pre-
natal diagnosis [25,26]. MMC prenatal diagnosis includes routine
screening of maternal serum alpha-fetal protein and ultrasound evalua-
tion between 16 and 20 weeks of gestation [27], although its clinical
usefulness has recently been shown to be limited [28]. Cellular profiling
by flow cytometry in bodily fluids can be used as a means of early diag-
nosis of MMC [29], as its efficacy has been confirmed in the diagnosis ofPlease cite this article as: Ceccarelli G, et al,Molecular signature of amniotic
J Pediatr Surg (2015), http://dx.doi.org/10.1016/j.jpedsurg.2015.04.014a variety of diseases such as urinary bladder cancer and acute nephritis
associated with systemic lupus erythematosus [30]. Moreover, the mo-
lecular profiling by real-time quantitative PCR technique has proven
useful in various clinical applications [31], and it may emerge as a future
complementary technique for prenatal diagnosis of MMC. Therefore,
the combination of imaging techniques and molecular tests on AF is es-
sential to identify the framework of the MMC.
In order to investigate this aspect, in this study we characterized the
AFSCs population isolated from theAF of the sheepmodel ofMMCby fo-
cusing on gene expression changes and metabolites’ variations in the
presence of neural tube defects. These cells were cultured in vitro
using a recently published protocol (De Coppi et al.) [13], which strictly
selects cells with mesenchymal markers (CD29+ CD44+ CD90+
CD105+) that would otherwise be absent in the other subset of cell
populations forming the AF environment. To the best of our knowledge,
this is the first study to propose stem cells of AF as ameans to stage fetal
neural tube defects in the MMC lambmodel. Sheep fetal AFs were used
to compare the population of AFSCs isolated from different stages of
gestations and interestingly before and after MMC induction, the mes-
enchymal stem cell profile was different (Fig. 3). We then analyzedfluid derived stem cells in the fetal sheepmodel ofmyelomeningocele,
6 G. Ceccarelli et al. / Journal of Pediatric Surgery xxx (2015) xxx–xxxthe molecular pattern of myogenic, chondrogenic and osteogenic pro-
genitor markers (meaning PAX3, HOXD4, HOXC8), which resulted dif-
ferent before and after MMC induction. Indeed these three genes have
an abrupt and similar increase in expression after the damage (16th
week), concomitant with the increased expression of CD34. However,
after the repair (20thweek) PAX3 levels returned to those observed be-
fore MMC induction.
These data suggest that surgical induction of fetal spinal lesions leads
to stem cell activation in amniotic fluid. CFU, XTT and AP assays demon-
strated the increased proliferation capability and stemness of the
cells four weeks after the intervention (Fig. 3). Quantitative RT-PCR
data have strengthened this hypothesis by showing the increase in ex-
pression of PAX3 and CD34, HOXD4, HOXC8 i.e. the genes involved in
muscular, chondrogenic and osteogenic repair respectively. Following
the surgically-induced MMC damage (16th week), the AF has an abrupt
increase of PAX3 positive progenitor cells with similar characteristics to
activated satellite cells [32], which persisted after inserting the collagen
biomatrix (20th week). PAX3 gene is very active in neural crest cells,
whichmigrate to specific regions in the embryo and contribute to specific
tissue formation including nerve tissue, craniofacial bones, muscle tissue
and melanocytes. Thus the high number of PAX3 progenitors represents
a biological marker of MMC and could be related to a tentative reparative
response. Consistently, loss of PAX3 protein function results in altered de-
velopment of craniofacial bones and certain muscles, producing the limb
and facial features typical of type 1 and type 2Waardenburg syndrome.
HOXD4 andHOXC8 are highly expressed in AFSCs both after theMMC
damage and its repairwith biomatrix (Fig. 4), strongly suggesting their in-
volvement in the repair. In addition, Kappen et al. correlated the overex-
pression of HOXD4 and HOXC8 in transgenic mice with severe cartilage
defects characterized by delayed maturation and accumulation of imma-
ture chondrocytes [33,34]. Moreover, Yueh et al. demonstrated the accu-
mulation of proliferating chondrocytes in vertebral cartilage caused by
HOXD4 andHOXC8 overexpression [35]. Hence, we propose that the sur-
gically induced damage strongly promotes proliferation and accumula-
tion of immature chondrogenic and osteogenic progenitors.
Metabolomic analysis of AF has been reported by several other
groups for the identification of possible AF biomarkers that could have
a predictive value in prenatal malformation detection [36]. Chi Y et al.
have analyzed the AF of neural tube defects patients, showing how the
metabolic changes of carbohydrates, nucleotides and amino acids
might be associated with impaired fetal growth and development
[37]. In our study, metabolic constituents such as muscle amino acids,
carbohydrates and nucleotide catabolites underwent changes after the
surgical repair of the MMC damage (Fig. 5). We hypothesized that the
surgical repair of the MMC damage triggers the proliferation and accu-
mulation of immature progenitors that reorganize their differentiation
commitment influencing metabolomics profile in order to accelerate
the mesodermal tissue repair. Hence, the early in utero repair may
help in the correct closure of the defect by favoring the intrinsic meso-
dermal tissue repair.
Itwas beyond the scopeof this preliminary study to analyze a compre-
hensive list of amniotic cell populations at different stages of gestation.
Due to the lack of molecular tools available for sheep animal models, we
could not analyze the populations of amniotic cells that might be affected
by the presence of a neural tube defect in this model. Nevertheless, we
have identified a cluster of genes (PAX3, HOXD4, HOXC8) that vary in
correlation with the creation and repair of the neural tube defect. We
strongly believe that the variation of expression in the gene cluster iden-
tified by qRT-PCR analysis in theMMC sheepmodel supports the role and
use of this technique for the prenatal evaluation of MMC in human.
In conclusion, AFSC profiling may become a useful diagnostic tool in
the prenatal evaluation of neural tube anomalies and highlights the
need for specific progenitors to counteract neural tube defects. Indeed
the presence of PAX3 positive cells in the amniotic fluid could reflect
the MMC damage and monitoring its expression may be useful for the
diagnosis of congenital neural tube defects.Please cite this article as: Ceccarelli G, et al, Molecular signature of amniotic
J Pediatr Surg (2015), http://dx.doi.org/10.1016/j.jpedsurg.2015.04.014Abbreviations
ACTB β-actin gene
AF amniotic fluid
AFSC amniotic fluid-derived stem cells
ANOVA analysis of variance
AP alkaline phosphatase
CFU colony forming unit
ELISAq enzyme-linked immunosorbent assay
GAPDH glyceraldehyde 3-phosphate dehydrogenase
GFAP glial fibrillary acidic protein gene
HOXC8 homeobox C8 gene
HOXD4 homeobox D4 gene
LASP1 LIM and SH3 protein 1 gene
MMC myelomeningocele
MTHFD1L methylenetetrahydrofolate dehydrogenase-1-like gene
MTHFR methylenetetrahydrofolate reductase gene
NMR nuclear magnetic resonance
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